SIC
TARO

SJS Investment Consulting’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

SJS Investment Consulting’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5
Closed -$122 – 1629
2023
Q1 		$122 Sell
5
-1
-17% -$29 ﹤0.01% 1437
2022
Q4 		$174 Buy
6
+2
+50% +$59 ﹤0.01% 1434
2022
Q3 		$0 Buy
+4
New +$138 ﹤0.01% 1651
2022
Q1 		$0 Buy
+1
New +$47 ﹤0.01% 1449

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

SJS Investment Consulting's TARO Position: Q2 2023 in Review

SJS Investment Consulting sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2023, closing a stake of 5 shares — an estimated $122 sold.

SJS Investment Consulting first reported a position in TARO in Q1 2022 and held it in 4 quarters. The position peaked at $174 in Q4 2022. 71 funds tracked by Wall St. Rank hold TARO as of Q2 2023.

  • SJS Investment Consulting reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2023 after selling out during the quarter.
  • SJS Investment Consulting sold 5 Taro Pharmaceutical Industries Ltd. shares in Q2 2023, an estimated $122.
  • SJS Investment Consulting first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2022 and held it in 4 quarters.
  • SJS Investment Consulting's Taro Pharmaceutical Industries Ltd. position peaked at $174 in Q4 2022.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2023.

Based on SJS Investment Consulting's 13F filing for Q2 2023, filed 13 Jul 2023.